Report Library
View More
Renal Cell Carcinoma (RCC) KOL Inte...
May 7, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 6, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 3, 2024
Melanoma KOL Interview - US, Midwes...
April 30, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Datamonitor Healthcare CV&Met Disea...
April 29, 2024
Datamonitor Healthcare I&I: Axial S...
April 29, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Melanoma KOL Interview - Germany
April 26, 2024
Datamonitor Healthcare Infectious D...
April 26, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/8/24 | COMPASS Pathways (CMPS) | COMP360 for Post-Traumatic Stress Disorder (PTSD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/6/24 | EyePoint Pharmaceuticals (EYPT) | Duravyu for Diabetic Retinopathy (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/6/24 | Inmagene Biopharmaceuticals | IMG-007 for Atopic Dermatitis (Eczema) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/6/24 | ImPact Biotech | Tookad for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/6/24 | ADC Therapeutics (ADCT) | Zynlonta for Marginal Zone Lymphoma - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/19/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/09/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/18/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |